Viking Global Investors ORIC trades
Ole Andreas Halvorsen
Ole Andreas Halvorsen Oric PharmaceuticalsInc stake
total: 682
Trades details
- Total transactions:
- 7
- New positions:
- 1
- Added:
- 2
- Reduced:
- 4
- Held for:
- 0 quarters
- Latest activity:
- 2026 Q3
According to 2026 Q3 report, Ole Andreas Halvorsen holds 3,562,915 Oric PharmaceuticalsInc (ORIC) shares with a market value of roughly $47.99M accounting for 0.15% of the overall portfolio. Viking Global Investors first purchased ORIC in 2024 Q1, initially acquiring about 4.00M shares. Since the initial investment in Oric PharmaceuticalsInc (ORIC), Viking Global Investors has made 6 more transactions.
When did Ole Andreas Halvorsen buy Oric PharmaceuticalsInc (ORIC)?
Ole Andreas Halvorsen first invested in Oric PharmaceuticalsInc (ORIC) in 2024 Q1 at the reported quarter-end price of $13.75 per share.
Ole Andreas Halvorsen's historical trades in Oric PharmaceuticalsInc
7 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q3
|
0.15%
|
3,562,915
|
$13.47
|
$47,992,465
|
-30.50% (-1,563,847)
|
-0.06%
|
|
2026 Q2
|
0.16%
|
5,126,762
|
$10.83
|
$55,522,832
|
-11.98% (-697,771)
|
-0.02%
|
|
2026 Q1
|
0.21%
|
5,824,533
|
$12.67
|
$73,796,833
|
-11.38% (-748,158)
|
-0.03%
|
|
2025 Q4
|
0.14%
|
6,572,691
|
$8.18
|
$53,764,612
|
-0.00% (-9)
|
0%
|
|
2025 Q1
|
0.12%
|
6,572,700
|
$5.58
|
$36,675,666
|
+48.33% (+2,141,692)
|
+0.04%
|
|
2024 Q4
|
0.12%
|
4,431,008
|
$8.07
|
$35,758,235
|
+10.78% (+431,008)
|
+0.01%
|
|
2024 Q1
|
0.20%
|
4,000,000
|
$13.75
|
$55,000,000
|
new
|
+0.2%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.